As of December 31, 2025, Arianne Phosphate Inc. carries a market capitalization of 43.81M, placing it among publicly traded companies globally. Its enterprise value stands at 72.20M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 43.81M |
| Enterprise Value | 72.20M |
As of December 31, 2025, Arianne Phosphate Inc. has 213.71M shares outstanding.
| Shares Outstanding | 213.71M |
As of December 31, 2025, Arianne Phosphate Inc. trades at a trailing price-to-earnings ratio of 1,025.60.
| PE Ratio | 1,025.60 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.39 |
| P/FCF Ratio | -18.58 |
| P/OCF Ratio | -19.52 |
As of December 31, 2025, Arianne Phosphate Inc. maintains a current ratio of 0.08, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 96.91, indicating elevated leverage, while an interest coverage ratio of -2.06 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.08 |
| Quick Ratio | 0.08 |
| Debt / Equity | 96.91 |
| Debt / EBITDA | -13.08 |
| Interest Coverage | -2.06 |
Over the twelve months ended December 31, 2025, Arianne Phosphate Inc. posted a return on equity (ROE) of 0.14, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) is negative at -3.77, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 0.06, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 1.86, useful for judging operating efficiency across full business cycles.
| Return on Equity (ROE) | 0.14 |
| Return on Assets (ROA) | 0.06 |
| Return on Invested Capital (ROIC) | -3.77 |
| Return on Capital Employed (ROCE) | 1.86 |
As of the close on October 22, 2026, Arianne Phosphate Inc.'s stock has gained approximately 21.95% over the past 52 weeks. The 50-day moving average sits at 0.31, while the 200-day moving average is 0.32.
| 52-Week Price Change | 21.95% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.32 |
Over the twelve months ended December 31, 2025, Arianne Phosphate Inc. generated - - in revenue and converted that into 42,177.00 in net income, yielding earnings per share of 0.00. EBITDA reached -2.33M, while operating income came in at -2.38M.
| Gross Profit | -27,540.00 |
| Operating Income | -2.38M |
| Pretax Income | 42,177.00 |
| Net Income | 42,177.00 |
| EBITDA | -2.33M |
| EBIT | -2.38M |
As of December 31, 2025, Arianne Phosphate Inc. holds 2.08M in cash and equivalents against 30.47M in total debt, resulting in a net debt position of 2.35M. Total book value stands at 31.44M, with working capital of -28.00M providing operational flexibility.
| Cash & Cash Equivalents | 2.08M |
| Total Debt | 30.47M |
| Net Debt | 2.35M |
| Equity (Book Value) | 31.44M |
| Book Value Per Share | 0.15 |
| Working Capital | -28.00M |
Arianne Phosphate Inc. produced -2.22M in operating cash flow over the twelve months ended December 31, 2025. After subtracting -139,161.00 in capital expenditures, free cash flow totaled -2.35M - equivalent to -0.01 per share.
| Operating Cash Flow | -2.22M |
| Capital Expenditures | -139,161.00 |
| Free Cash Flow | -2.35M |
| FCF Per Share | -0.01 |
These figures cover the twelve months ended December 31, 2025. Free cash flow yield is negative at -5.38: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.09, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Arianne Phosphate Inc. shareholders.
| Shareholder Yield | 0.09 |
| FCF Yield | -5.38 |
Arianne Phosphate Inc.'s most recent stock split took place on July 3, 2009 with a 5:1 split ratio.
| Last Split Date | 7/3/2009 |
| Split Ratio | 5:1 |
As of December 31, 2025, Arianne Phosphate Inc. has an Altman Z-Score of -1.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.77 |
Already premium?